Top menu
Main menu
Main Content
BLAVATNIK CENTER for Drug Discovery
Tel Aviv University
BMM
BCDD
Search
This site
Global search
About
Who Are We?
Welcome
About Us
Director's Page
Overview
Activities
Virtual Tour
People
BCDD People
Management
Our People
Research
BCDD Units
Computer-Aided Drug Design
HTS Biological Assays
Medicinal Chemistry
Industrial Services
Computational Services
Chemistry Services
Biological Services
Equipment
Publications
Scientific Publications
BMM Division
Metabolite Medicine
BMM Division
Headlines
BCDD Headlines
Newsroom
Media Coverage
Conferences
Galleries
Open Positions
Contact
Contact Us
Contact Info
Map & Directions
Metabolomics - A New Frontier in Preventive Medicine
Tel Aviv University's new Metabolite Medicine Division at the BLAVATNIK Center for Drug Discovery poised to revolutionize the field
Jul 20th, 2023
Research
Metabolomics - A New Frontier in Preventive Medicine
Jan 24th, 2023
Prof. Ehud Gazit Elected Fellow of the US National Academy of Inventors
Feb 28th, 2022
International Rare Disease Day: Studying rare diseases at the BCDD
Oct 14th, 2021
2021 Nobel Prize in Physiology on the Role of TRP Family of Ion Channels
You are here
Homepage of Tel Aviv University
>
BCDD
>
Headlines
>
BCDD Headlines
> News Research Lobby
NEWS
What are you interested in?
All topics
Drug Development
Official Visit
Publication
Symposium
Training
Rare Diseases
Researches
Awards
Grants
New Article
שיוך לתחומים (field_research_zone)
שיוך לתחומים (field_news_belong_area)
Breast Cancer
Drug Development
Training
Official Visit
Metabolomics
Life Sciences
Rare Diseases
Research
Grants
Awards
שיוך לתחומים חדש (field_belong_domains)
- Any -
Drug Development
Official Visit
Publication
Symposium
Training
Rare Diseases
Researches
Awards
Grants
New Article
Jul 17th, 2019
British Ambassador to Israel visited BCDD
This is the first official visit to Tel Aviv University for Britain's new ambassador to Israel, Mr. Neil Wigan
Official Visit
Jun 25th, 2019
Weizmann Institute hosted the 16th Annual Meeting of Medicinal Chemistry section
The BCDD was part of the meeting organizing committee and sponsors
Symposium
Jun 25th, 2019
BCDD researchers attended RSC Medicinal Chemistry Residential School
The 2019 course was conducted at Loughborough, UK, and covered topics of interest in drug discovery
Training
Jun 16th, 2019
BCDD and EU-OPENSCREEN aiming for cooperation
Israeli researchers visited EU-OPENSCREEN headquarters and FMP Germany to discuss future collaborations
Apr 17th, 2019
BCDD launch Board Members Seminar Series
At a seminar took place earlier this week Prof. Adam Cohen and Prof. William DeGrado presented their work and vision for academic drug discovery
Symposium
Mar 12th, 2019
The President of Israel visited the BCDD
The BLAVATNIK CENTER for Drug Discovery hosted Mr. Rivlin as a part of his delegation's visit to TAU's campus
Official Visit
Jan 22nd, 2019
BCDD researchers get advanced training in metabolomics
Dr. Avi Raveh and Dr. Shira Shaham-Niv gained hands-on experience in various aspects of metabolomics
Training
Jan 9th, 2019
Congratulations to Dr. Dana Laor from Ehud Gazit's lab for her publication
The article, "Fibril formation and therapeutic targeting of amyloid-like structures in a yeast model of adenine accumulation", was published in "Nature Communications"
Publication
Dec 4th, 2018
An innovation delegation from Western India visited the BCDD
20 members of the delegation toured the center as a part of the Foreign Ministry's effort to strengthen ties between Israel and India
Official Visit
Oct 8th, 2018
BCDD and Sagol School hosted Child Health Conference
The conference focused on new therapeutic and technological approaches for treating neurodevelopmental disorders and rare diseases
Symposium
Aug 15th, 2018
Alpha youngsters visited BCDD
The center hosted a group of 9th-grade students from the Alpha program - a research program for gifted students operated by TAU through Tel Aviv Youth University
Official Visit
Show More
Tel Aviv University makes every effort to respect copyright. If you own copyright to the content contained
here and / or the use of such content is in your opinion infringing,
Contact us as soon as possible >>